AB 2095 — Medi-Cal: prescriptions.
Last action — In committee: Set, first hearing. Hearing canceled at the request of author.
-
✓Introduced
-
2In Committee
-
3Passed Assembly
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill died with 2015-2016 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.
Summary
Existing law establishes the Medi-Cal program, administered by the State Department of Health Care Services, under which health care services are provided to qualified, low-income persons. The Medi-Cal program is, in part, governed and funded by federal Medicaid Program provisions. This bill would require the Legislative Analyst's Office to conduct or cause to be conducted a study comparing the purchase or administration of brand name prescription medications through the Medi-Cal program to the purchase or administration of biosimilars through the Medi-Cal program, as specified. The bill would require the study to cover the 2013–14 and 2014–15 fiscal years and to be completed on or before January 1, 2018.
Bill Text
- Amended 03/18/16 - Amended Assembly Current pdf March 18, 2016
- Introduced 02/17/16 - Introduced pdf February 17, 2016
- AB2095 View text html
Action History
-
In committee: Set, first hearing. Hearing canceled at the request of author.
-
Re-referred to Com. on HEALTH.
-
From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended.
-
Referred to Com. on HEALTH.
-
From printer. May be heard in committee March 19.
-
Read first time. To print.
Sponsors
- Travis Allen · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 121 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (121)
121 members have not signed on to this bill.
Show all 121 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does AB 2095 do?
- Existing law establishes the Medi-Cal program, administered by the State Department of Health Care Services, under which health care services are provided to qualified, low-income persons. The Medi-Cal program is, in part, governed and funded by federal Medicaid Program provisions. This bill would require the Legislative Analyst's Office to conduct or cause to be conducted a study comparing the purchase or administration of brand name prescription medications through the Medi-Cal program to the purchase or administration of biosimilars through the Medi-Cal program, as specified. The bill would require the study to cover the 2013–14 and 2014–15 fiscal years and to be completed on or before January 1, 2018.
- Who sponsors AB 2095?
- AB 2095 is sponsored by Travis Allen.
- What is the current status of AB 2095?
- This bill died with 2015-2016 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track AB 2095?
- Track AB 2095 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on AB 2095
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of AB 2095
Last checked for changes 2 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →